Nomad Health, Inc. operates an online marketplace that connects healthcare professionals with freelance and permanent job opportunities in the United States. Founded in 2015 and based in New York, the platform allows doctors and nurses to search for positions by various criteria, including location and pay rate. By streamlining the healthcare staffing process, Nomad Health aims to simplify job searches for medical professionals and facilitate the hiring needs of healthcare facilities. This modern technology platform addresses the complexities of traditional healthcare staffing, promoting efficiency and accessibility in the job market.
Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in the development and manufacturing of medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. Its flagship product, SteriPath, is a vacuum-assisted blood collection system designed to divert contaminants from the initial blood sample, thereby reducing the incidence of blood culture sample contamination. The company markets its products through distributors across the United States and has built a robust intellectual property portfolio, consisting of over 70 issued patents and more than 50 pending applications. Founded in 2011, Magnolia Medical Technologies is committed to improving diagnostic specimen quality and increasing the accuracy of critical laboratory tests.
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.
RareCyte, Inc. is a life sciences company based in Seattle, Washington, that specializes in the development of liquid and tissue biopsy analysis platforms aimed at the detection of rare cells. Founded in 2009, RareCyte focuses on providing innovative technologies for the Life Sciences research, drug development, and diagnostic markets. The company offers a range of products, including sample preparation systems, staining kits, and automated fluorescence microscopy instruments. Its AccuCyte system is particularly notable for enabling the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. RareCyte's technologies are designed to address complex challenges in cancer and cardiovascular disease research, facilitating advancements in precision medicine and non-invasive prenatal testing.
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.
EverlyWell develops do-it-yourself kits for a vast range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid, and metabolism among the others, allowing users to perform tests at home and receive physician-reviewed results and insights on their mobile devices. EverlyWell also provides at-home covid testing.
TigerConnect is a healthcare communication platform designed to enhance collaboration among healthcare professionals, patients, and care providers. Founded in 2010 and based in Santa Monica, California, the company offers real-time mobile messaging that combines a user-friendly experience with robust security and privacy features. Trusted by over 4,000 healthcare organizations, TigerConnect processes more than 10 million messages daily and boasts a 99.99% uptime. The platform facilitates effective communication and workflow integration with critical hospital systems, ultimately aiming to improve productivity, reduce costs, and enhance patient outcomes. TigerConnect's commitment to client success is evident in its comprehensive support services, which assist organizations in optimizing communication workflows.
Pulmonx Corporation is a medical technology company focused on developing minimally invasive devices for diagnosing and treating chronic obstructive pulmonary disease (COPD), particularly severe emphysema. The company offers key products including the Zephyr Endobronchial Valve, which addresses hyperinflation in adult patients, and the Chartis Pulmonary Assessment System, a tool that evaluates collateral ventilation through flow and pressure measurements. Additionally, Pulmonx provides the StratX Lung Analysis Platform, a cloud-based service that utilizes computed tomography to analyze lung conditions, aiding in the identification of treatment targets for the Zephyr Valve. With a strong clinical foundation supported by numerous published studies, Pulmonx has received regulatory recognition, including FDA approval for its Zephyr Valve, which is now used by physicians in over 25 countries. The company aims to enhance the quality of life for emphysema patients worldwide, having facilitated the treatment of more than 19,000 patients with over 76,000 valves deployed. Founded in 1995 and headquartered in Redwood City, California, Pulmonx continues to lead in interventional procedures for COPD treatment.
Perspectum Diagnostics Ltd. is a medical technology company based in Oxford, United Kingdom, with additional offices in Singapore and the United States. Founded in 2012, it specializes in developing innovative technologies for diagnosing and measuring liver diseases through advanced magnetic resonance imaging. The company's flagship product, LiverMultiScan, provides objective and quantitative assessments of liver health, aiding in the detection and measurement of liver, gallbladder, and pancreatic diseases, including precancerous and cancerous conditions. Perspectum's technologies are also utilized in clinical trials to evaluate investigational therapies for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. By focusing on precision medicine, Perspectum aims to enhance patient care through early detection, accurate diagnosis, and targeted treatment, leveraging a diverse team of experts in medicine and technology. As of March 2020, the company operates as a subsidiary of Ambra Health, Inc.
RareCyte, Inc. is a life sciences company based in Seattle, Washington, that specializes in the development of liquid and tissue biopsy analysis platforms aimed at the detection of rare cells. Founded in 2009, RareCyte focuses on providing innovative technologies for the Life Sciences research, drug development, and diagnostic markets. The company offers a range of products, including sample preparation systems, staining kits, and automated fluorescence microscopy instruments. Its AccuCyte system is particularly notable for enabling the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. RareCyte's technologies are designed to address complex challenges in cancer and cardiovascular disease research, facilitating advancements in precision medicine and non-invasive prenatal testing.
Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, specializing in innovative solutions for aesthetic treatments. Founded in 2009, the company offers a diverse range of products, including Venus Versa, a multi-treatment platform for non-surgical procedures; Venus Legacy, designed for skin tightening and body contouring; and Venus Viva, a customizable skin resurfacing device. Additionally, Venus Concept provides Venus Freeze Plus for anti-aging and non-invasive skin tightening, and Venus Bliss for fat reduction. The company also features advanced hair restoration technologies, including NeoGraft and ARTAS robotic systems, which streamline the follicle harvesting process. Committed to ethical practices and technological advancement, Venus Concept aims to enhance the patient experience in the medical aesthetics industry.
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.
Bardy Diagnostics, Inc. is a medical device company that specializes in the development and manufacturing of cardiac monitoring solutions, primarily focused on arrhythmia detection. Its flagship product, the Carnation Ambulatory Monitor (CAM), is a lightweight, discreet cardiac patch that can be worn comfortably for up to seven days, even during physical activities like exercise or showering. The CAM is designed with a unique hourglass shape to enhance comfort, particularly for female patients. Complementing the monitor is the BDxCONNECT patient management system, which allows healthcare providers to create and manage patient reports efficiently. By utilizing innovative P-wave centric ECG detection technology, Bardy Diagnostics aims to improve clinical management and outcomes for patients and their physicians. Founded in 2013, the company is headquartered in Seattle, Washington, with additional offices in Houston, Texas, and New Providence, New Jersey.
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.
Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in the development and manufacturing of medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. Its flagship product, SteriPath, is a vacuum-assisted blood collection system designed to divert contaminants from the initial blood sample, thereby reducing the incidence of blood culture sample contamination. The company markets its products through distributors across the United States and has built a robust intellectual property portfolio, consisting of over 70 issued patents and more than 50 pending applications. Founded in 2011, Magnolia Medical Technologies is committed to improving diagnostic specimen quality and increasing the accuracy of critical laboratory tests.
Private Equity Round in 2019
Etairos Health, Inc., doing business as Harmony Home Health, provides non-skilled home-based care for the elderly in Florida and southeastern markets. The company's services include care while recovering from an illness or fall, assisting with mobility, helping with showering or bathing, preparing meals, and light housekeeping. The company was founded in 2004 and is headquartered in Largo, Florida.
Trice Medical, Inc. specializes in developing orthopedic diagnostic devices that incorporate camera-enabled technologies and needle-based systems. Founded in 2011 and based in Malvern, Pennsylvania, the company aims to enhance orthopedic diagnostics by providing instant and accurate visual insights for patients, physicians, and payors. Trice Medical's innovative products facilitate minimally invasive procedures that can be performed in an office setting, offering painless and cosmetically undetectable solutions for both diagnostic and therapeutic purposes. The company's technology addresses the shortcomings of traditional diagnostic methods, significantly reducing false readings and overall healthcare costs, while optimizing the delivery of patient care.
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.
CleanSlate Centers, LLC operates a network of outpatient addiction treatment centers across the United States, focusing on helping individuals overcome various substance dependencies, including opioids, alcohol, cocaine, benzodiazepines, and tobacco. Founded in 2009 and headquartered in Northampton, Massachusetts, the company provides a range of treatment programs, including medication-assisted therapies utilizing Suboxone and Vivitrol, as well as psychiatric care and hepatitis C treatment. With locations in states such as Arizona, Connecticut, Florida, Indiana, Massachusetts, Pennsylvania, Texas, and Wisconsin, CleanSlate Centers aims to deliver accessible and professional support to patients seeking to overcome their addictions. Additionally, the organization engages in research and educational initiatives to further enhance its treatment offerings.
Avedro, Inc. is an ophthalmic pharmaceutical and medical device company that specializes in developing and commercializing products for treating corneal disorders, particularly those associated with corneal weakness. The company's primary offering is the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems, designed to deliver ultraviolet A (UVA) light alongside various single-use riboflavin drug formulations. This platform addresses corneal ectatic disorders and refractive conditions, with specific applications in treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also offers the Keraflex procedure, a non-invasive technique for corneal reshaping that preserves corneal integrity. The company's products are primarily marketed to ophthalmologists, hospitals, and ambulatory surgery centers both in the United States and internationally through a network of distributors. Avedro, which was incorporated in 2002 and is headquartered in Waltham, Massachusetts, operates as a subsidiary of Glaukos Corporation.
BioIQ, Inc. is a healthcare engagement and quality care company based in Atlanta, Georgia, founded in 2005. The company specializes in developing health measurement software solutions that enhance corporate health and wellness programs. BioIQ offers a unique health screening platform and an ecosystem of health improvement tools, enabling employers, health plans, and government entities to implement customizable and measurable health initiatives. With a focus on analytics and omnichannel communications, BioIQ aims to optimize investments in health programs and improve patient navigation within the U.S. healthcare system. The company has successfully launched over 3,000 health improvement programs and serves a diverse clientele, including national laboratories and diagnostics companies, helping beneficiaries across the nation achieve better health outcomes.
Springbuk, Inc. operates a health analytics platform aimed at employers, brokers, and vendors. Founded in 2015 and based in Indianapolis, Indiana, the company offers cloud-based health intelligence software that integrates various data sources, including medical claims, pharmacy records, biometric information, payroll, and activity data. This unified platform allows employers to assess employee health and wellness, make informed budget and spending decisions, and identify at-risk employees. Additionally, Springbuk’s predictive modeling engine enhances employer engagement strategies by accurately forecasting healthcare costs and measuring the effectiveness of wellness programs.
Vestagen Technical Textiles is a company based in Orlando, Florida, that develops, manufactures, and markets high-performance textile products for the healthcare sector and beyond. Founded in 2009, it offers a range of items including lab coats and uniforms specifically designed for specialty healthcare workers and patients. The company holds exclusive North American rights to patented Swiss technologies that enable the adaptation of its textiles for various applications, including medical uniforms and athletic apparel. Vestagen sells its products directly to consumers and through retail partners, distributors, and online platforms, ensuring broad accessibility to its innovative textile solutions.
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.
Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, specializing in innovative solutions for aesthetic treatments. Founded in 2009, the company offers a diverse range of products, including Venus Versa, a multi-treatment platform for non-surgical procedures; Venus Legacy, designed for skin tightening and body contouring; and Venus Viva, a customizable skin resurfacing device. Additionally, Venus Concept provides Venus Freeze Plus for anti-aging and non-invasive skin tightening, and Venus Bliss for fat reduction. The company also features advanced hair restoration technologies, including NeoGraft and ARTAS robotic systems, which streamline the follicle harvesting process. Committed to ethical practices and technological advancement, Venus Concept aims to enhance the patient experience in the medical aesthetics industry.
Trice Medical, Inc. specializes in developing orthopedic diagnostic devices that incorporate camera-enabled technologies and needle-based systems. Founded in 2011 and based in Malvern, Pennsylvania, the company aims to enhance orthopedic diagnostics by providing instant and accurate visual insights for patients, physicians, and payors. Trice Medical's innovative products facilitate minimally invasive procedures that can be performed in an office setting, offering painless and cosmetically undetectable solutions for both diagnostic and therapeutic purposes. The company's technology addresses the shortcomings of traditional diagnostic methods, significantly reducing false readings and overall healthcare costs, while optimizing the delivery of patient care.
Avedro, Inc. is an ophthalmic pharmaceutical and medical device company that specializes in developing and commercializing products for treating corneal disorders, particularly those associated with corneal weakness. The company's primary offering is the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems, designed to deliver ultraviolet A (UVA) light alongside various single-use riboflavin drug formulations. This platform addresses corneal ectatic disorders and refractive conditions, with specific applications in treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also offers the Keraflex procedure, a non-invasive technique for corneal reshaping that preserves corneal integrity. The company's products are primarily marketed to ophthalmologists, hospitals, and ambulatory surgery centers both in the United States and internationally through a network of distributors. Avedro, which was incorporated in 2002 and is headquartered in Waltham, Massachusetts, operates as a subsidiary of Glaukos Corporation.
Avizia is a provider of telehealth and remote conferencing platform to deploy and power system-wide telehealth programs. It is delivering on the vision of collaborative care for patients by connecting medical experts across distance through innovative, leading-edge telemedicine solutions. Supported by Cisco technology, Avizia delivers telemedicine that is as powerful as it is easy to use. Its end-to-end solution includes telemedicine devices, workflow management software, store-and-forward capabilities with EHR integration, and a line of peripherals, such as digital stethoscopes and examination cameras. Whether medical professionals are performing remote medical consultations or teaching a new procedure, Avizia makes the experience feel as if everyone is present. Avizia uses Cisco TelePresence technology to enable HD, real-time video collaboration in hospitals amongst patients and professionals.
Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in the development and manufacturing of medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. Its flagship product, SteriPath, is a vacuum-assisted blood collection system designed to divert contaminants from the initial blood sample, thereby reducing the incidence of blood culture sample contamination. The company markets its products through distributors across the United States and has built a robust intellectual property portfolio, consisting of over 70 issued patents and more than 50 pending applications. Founded in 2011, Magnolia Medical Technologies is committed to improving diagnostic specimen quality and increasing the accuracy of critical laboratory tests.
Avizia is a provider of telehealth and remote conferencing platform to deploy and power system-wide telehealth programs. It is delivering on the vision of collaborative care for patients by connecting medical experts across distance through innovative, leading-edge telemedicine solutions. Supported by Cisco technology, Avizia delivers telemedicine that is as powerful as it is easy to use. Its end-to-end solution includes telemedicine devices, workflow management software, store-and-forward capabilities with EHR integration, and a line of peripherals, such as digital stethoscopes and examination cameras. Whether medical professionals are performing remote medical consultations or teaching a new procedure, Avizia makes the experience feel as if everyone is present. Avizia uses Cisco TelePresence technology to enable HD, real-time video collaboration in hospitals amongst patients and professionals.
Spirox, Inc. is a medical device company headquartered in Menlo Park, California, focused on improving the quality of life for patients suffering from nasal obstruction due to nasal valve collapse. Formerly known as Nasoform LLC, the company develops innovative solutions to address this common but often undertreated condition. Their flagship product, the LATERA absorbable nasal implant, aims to provide effective treatment for nasal valve collapse, enhancing nasal airflow and overall patient comfort. Founded in 2011, Spirox operates as a subsidiary of Entellus Medical, Inc. and is actively involved in completing product development, seeking U.S. marketing authorization, and initiating commercialization efforts.
Vestagen Technical Textiles is a company based in Orlando, Florida, that develops, manufactures, and markets high-performance textile products for the healthcare sector and beyond. Founded in 2009, it offers a range of items including lab coats and uniforms specifically designed for specialty healthcare workers and patients. The company holds exclusive North American rights to patented Swiss technologies that enable the adaptation of its textiles for various applications, including medical uniforms and athletic apparel. Vestagen sells its products directly to consumers and through retail partners, distributors, and online platforms, ensuring broad accessibility to its innovative textile solutions.
BioTheranostics, Inc. is a commercial-stage molecular diagnostics company focused on developing and providing proprietary diagnostic tests that aid physicians in making informed decisions regarding cancer treatment. The company offers several key products, including the Breast Cancer Index, which assists oncologists in determining the appropriateness of extended endocrine therapy for patients with estrogen receptor-positive breast cancer. Additionally, CancerTYPE ID delivers critical genomic information for the diagnosis and management of metastatic cancer, while the bioT3 metastatic cancer solution integrates precise molecular diagnosis with extensive biomarker data to enhance treatment options for metastatic cancer patients. Founded in 1996 and headquartered in San Diego, California, BioTheranostics aims to support personalized medicine by ensuring that every patient receives a tailored care plan.
First Aid Shot Therapy is a company specializing in clinical beverages aimed at addressing acute and chronic health needs. Founded in 2010 and headquartered in Burlingame, California, it offers a variety of easy-to-swallow, single-dose products that deliver fast-acting relief for common everyday symptoms such as hangovers, pain, sleep issues, colds, allergies, and heartburn. The company's focus is on providing effective solutions that help consumers manage their symptoms quickly and conveniently.
Inmediata, previously known as Secure EDI, is a technology company focused on enhancing efficiency and reducing costs in the healthcare sector. The company specializes in creating seamless connections between healthcare providers and payers, facilitating the secure online processing of claim and payment transactions. Inmediata offers a comprehensive electronic transaction management platform that includes services such as real-time claims adjudication, electronic funds transfer, and the conversion of paper transactions to electronic formats. Additionally, the platform supports online reconciliation and data analysis, improving the overall billing and payment processes for hospitals and physician offices. By streamlining these transactions, Inmediata aims to simplify the healthcare billing experience for both providers and patients.
Vestagen Technical Textiles is a company based in Orlando, Florida, that develops, manufactures, and markets high-performance textile products for the healthcare sector and beyond. Founded in 2009, it offers a range of items including lab coats and uniforms specifically designed for specialty healthcare workers and patients. The company holds exclusive North American rights to patented Swiss technologies that enable the adaptation of its textiles for various applications, including medical uniforms and athletic apparel. Vestagen sells its products directly to consumers and through retail partners, distributors, and online platforms, ensuring broad accessibility to its innovative textile solutions.
Castle Biosciences, we focus on addressing this gap. We work with leading cancer institutions to in-license proprietary technologies and complete development and validation. The ultimate goal is to make these proven tests available to all individuals afflicted with a rare cancer.
Trice Medical, Inc. specializes in developing orthopedic diagnostic devices that incorporate camera-enabled technologies and needle-based systems. Founded in 2011 and based in Malvern, Pennsylvania, the company aims to enhance orthopedic diagnostics by providing instant and accurate visual insights for patients, physicians, and payors. Trice Medical's innovative products facilitate minimally invasive procedures that can be performed in an office setting, offering painless and cosmetically undetectable solutions for both diagnostic and therapeutic purposes. The company's technology addresses the shortcomings of traditional diagnostic methods, significantly reducing false readings and overall healthcare costs, while optimizing the delivery of patient care.
Lineagen, Inc. is a genetics diagnostic company based in Salt Lake City, Utah, specializing in genetic testing and clinical information services for neurodevelopmental disorders, particularly autism. Founded in 2002, the company offers a range of diagnostic tools, including FirstStepDx PLUS, a chromosomal microarray platform designed to identify genomic changes related to autism and other neurodevelopmental disorders, and NextStepDx PLUS, a genetic sequencing test for detecting small genomic alterations. Additionally, Lineagen provides M-CHAT.org, an online screening resource for developmental evaluation. The company focuses on improving outcomes for individuals with autism and other complex diseases by enabling early diagnosis and intervention. Lineagen's research capabilities are enhanced by its access to the Utah Population Database through the University of Utah, which supports significant discoveries in disease-related genetics. As of August 2020, Lineagen operates as a subsidiary of Bionano Genomics, Inc.
Castle Biosciences, we focus on addressing this gap. We work with leading cancer institutions to in-license proprietary technologies and complete development and validation. The ultimate goal is to make these proven tests available to all individuals afflicted with a rare cancer.